Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers.


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
01 02 2023
Historique:
received: 21 08 2022
accepted: 30 10 2022
entrez: 27 1 2023
pubmed: 28 1 2023
medline: 1 2 2023
Statut: epublish

Résumé

App-based technologies could enhance patient and caregiver communication and provide alerts that potentially reducing readmissions. However, the burden of App alerts needs to be optimized to reduce provider burnout. The purpose of this study was to determine subjective and objective burden of using the Patient Buddy App, a health information technology (HIT) on providers in a randomized multicenter trial, who completed a semi-quantitative Likert scale survey regarding training procedures, data and privacy concerns, follow-up details, and technical support. This randomized multicenter trial recruits cirrhosis inpatients and their caregivers, and randomizes them into standard-of-care, HIT (communication only via App) and HIT+visits (App+phone calls/visits) for 30 days after discharge. The alerts are monitored by providers through a central iPad. The reason(s) and number of alerts were recorded as the objective burden. A total of 1442 messages were sent as alerts from the 103 dyads (patient + caregiver) (n=206) randomized to HIT arms. The most common messages related to Hepatic Encephalopathy (HE) (high or low bowel movement=50% or orientation tests=37%). Twelve providers completed the surveys reflecting the following themes-92% and 100%, felt adequately trained and confident about educating the patients and caregivers before roll out of App and had no concerns related to data and privacy; 70%, felt that appropriate time was spent on pursuing reason for data not being logged; 60% each, had issues with availability of adequate technical support and connectivity. The Patient Buddy App randomized multicenter trial till date shows an overall favorable rating regarding training procedures/education, privacy concerns, and ease of message follow-up, from providers. However, it is important to gauge and address subjective and objective burdens of monitoring human resources in current and future HIT studies to avoid burnout and to ensure successful study completion.

Sections du résumé

BACKGROUND
App-based technologies could enhance patient and caregiver communication and provide alerts that potentially reducing readmissions. However, the burden of App alerts needs to be optimized to reduce provider burnout.
AIM
The purpose of this study was to determine subjective and objective burden of using the Patient Buddy App, a health information technology (HIT) on providers in a randomized multicenter trial, who completed a semi-quantitative Likert scale survey regarding training procedures, data and privacy concerns, follow-up details, and technical support. This randomized multicenter trial recruits cirrhosis inpatients and their caregivers, and randomizes them into standard-of-care, HIT (communication only via App) and HIT+visits (App+phone calls/visits) for 30 days after discharge. The alerts are monitored by providers through a central iPad. The reason(s) and number of alerts were recorded as the objective burden. A total of 1442 messages were sent as alerts from the 103 dyads (patient + caregiver) (n=206) randomized to HIT arms. The most common messages related to Hepatic Encephalopathy (HE) (high or low bowel movement=50% or orientation tests=37%). Twelve providers completed the surveys reflecting the following themes-92% and 100%, felt adequately trained and confident about educating the patients and caregivers before roll out of App and had no concerns related to data and privacy; 70%, felt that appropriate time was spent on pursuing reason for data not being logged; 60% each, had issues with availability of adequate technical support and connectivity.
CONCLUSION
The Patient Buddy App randomized multicenter trial till date shows an overall favorable rating regarding training procedures/education, privacy concerns, and ease of message follow-up, from providers. However, it is important to gauge and address subjective and objective burdens of monitoring human resources in current and future HIT studies to avoid burnout and to ensure successful study completion.

Identifiants

pubmed: 36706194
doi: 10.1097/HC9.0000000000000030
pii: 02009842-202302010-00016
pmc: PMC9988316
doi:

Types de publication

Randomized Controlled Trial Multicenter Study Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0030

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.

Références

Endosc Int Open. 2019 Feb;7(2):E216-E224
pubmed: 30705956
J Am Med Inform Assoc. 2021 Apr 23;28(5):895-898
pubmed: 33871016
J Med Internet Res. 2021 Apr 9;23(4):e24639
pubmed: 33744844
Dig Dis Sci. 2022 Mar;67(3):854-862
pubmed: 34018070
Am J Gastroenterol. 2022 Mar 1;117(3):491-494
pubmed: 35020619
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1181-1188.e2
pubmed: 27085758
Curr Gastroenterol Rep. 2017 Jan;19(1):1
pubmed: 28101791
BMC Bioinformatics. 2012 May 16;13:99
pubmed: 22591066
Ann Intern Med. 2018 Jul 3;169(1):50-51
pubmed: 29801050
Hepatology. 2020 Aug;72(2):723-728
pubmed: 32275784
Liver Int. 2017 Dec;37(12):1843-1851
pubmed: 28618192
JMIR Med Inform. 2020 Sep 2;8(9):e17770
pubmed: 32876581
Hepatology. 2016 Jul;64(1):200-8
pubmed: 26690389

Auteurs

Jawaid Shaw (J)

Division of Hospital Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Chathur Acharya (C)

Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Somaya Albhaisi (S)

Division of Hospital Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Andrew Fagan (A)

GI Section, Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.

Sara McGeorge (S)

Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Melanie B White (MB)

Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Jatinder Lachar (J)

Division of Hospital Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.

Jessica Olson (J)

Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.

Amy Olofson (A)

Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.

Lori Bergstrom (L)

Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.

Patrick S Kamath (PS)

Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.

Jasmohan S Bajaj (JS)

Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
GI Section, Central Virginia Veterans Healthcare System, Richmond, Virginia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH